Reuters: Health
A Singaporean biotechnology firm, Tychan, will begin human clinical trials next week for a potential monoclonal antibody treatment for COVID-19, it said in a statement on Wednesday.
Singapore biotech firm Tychan to start human trials for COVID-19 treatment next week
Singapore biotech firm Tychan to start human trials for COVID-19 treatment next week
Reuters: Health
A Singaporean biotechnology firm, Tychan, will begin human clinical trials next week for a potential monoclonal antibody treatment for COVID-19, it said in a statement on Wednesday.
Reuters: Health
A Singaporean biotechnology firm, Tychan, will begin human clinical trials next week for a potential monoclonal antibody treatment for COVID-19, it said in a statement on Wednesday.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment